Kelly RJ et al. found that a significant shift from PD-L1− to PD-L1+ status in 50% advanced esophageal adenocarcinoma patients post chemo-radiation (OR = 6.5, p < 0.01) [42]. This evidence concerns the gene CD274 and esophageal adenocarcinoma.